United States· US:70727-529_37be9b45-067b-4ed3-a455-92a4be4b1a25

Rocklatan

A latanoprost and netarsudil product containing netarsudil mesylate; latanoprost, registered in United States by Alcon Laboratories, Inc.. The same ATC class is registered in 14 of our 19 countries.

ATC S01EE51US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedRocklatanATCS01EE51REGISTER NO.US:70727-529_37be9b45…PACKS LISTED4CHECKEDAugust 30, 2026

Where it is registered

Latanoprost and netarsudil is registered in 14 of 19 countries.

Countries holding a registration under ATC S01EE51 (latanoprost and netarsudil), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Latanoprost and netarsudil · ATC S01EE51

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NETARSUDIL MESYLATE; LATANOPROST
Manufacturer
Alcon Laboratories, Inc.
Country
United States (US)
ATC code
S01EE51
ATC class
Latanoprost and netarsudil
Defined daily dose
0.1 ml, AT
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 30, 2026

Packs & prices · 4

  • ndc11
    7072752925
    1 BOTTLE, PLASTIC in 1 CARTON (70727-529-25) / 2.5 mL in 1 BOTTLE, PLASTIC
  • ndc11
    7072752999
    1 BOTTLE, PLASTIC in 1 CARTON (70727-529-99) / 2.5 mL in 1 BOTTLE, PLASTIC
  • ndc11
    70727-529-25
  • ndc11
    70727-529-99

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Latanoprost and netarsudil in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All latanoprost and netarsudil products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Roclanda
  • Liechtenstein · Roclanda
  • Norway · Roclanda

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/541b4ad4-456e-4b01-aeb6-bab0497d303f
GET /v1/drugs/541b4ad4-456e-4b01-aeb6-bab0497d303f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC; TOPICAL",
  "source": "ndc",
  "strength": ".2; .05",
  "substance": "NETARSUDIL MESYLATE; LATANOPROST",
  "productndc": "70727-529",
  "dosage_form": "SOLUTION/ DROPS",
  "dea_schedule": null,
  "strength_unit": "mg/mL; mg/mL",
  "application_number": "NDA208259",
  "marketing_category": "NDA"
}

See everything about latanoprost and netarsudil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.